Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引：20
|
作者：
Hoelzer, S
Steiner, D
Bauer, R
Reiners, C
Farahati, J
Hundahl, SA
Dudeck, J
机构：
[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany
[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany
[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany
[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2000年 / 27卷 / 10期
关键词：
differentiated thyroid cancer; guidelines; radioiodine; treatment;
D O I：
10.1007/s002590000333
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.
引用
收藏
页码：1465 / 1472
页数：8
相关论文
共 50 条
  • [41] Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
    Molenaar, Remco J.
    Sidana, Surbhi
    Radivoyevitch, Tomas
    Advani, Anjali S.
    Gerds, Aaron T.
    Carraway, Hetty E.
    Angelini, Dana
    Kalaycio, Matt
    Nazha, Aziz
    Adelstein, David J.
    Nasr, Christian
    Maciejewski, Jaroslaw P.
    Majhail, Navneet S.
    Sekeres, Mikkael A.
    Mukherjee, Sudipto
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1831 - +
  • [42] The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer
    Ahmet Numan Demir
    Zehra Kara
    Cem Sulu
    Serhat Uysal
    Guldana Zulfaliyeva
    Oznur Aydin Atar
    Nahida Valikhanova
    Tulin Ozturk
    Hande Mefkure Ozkaya
    Taner Damci
    Mustafa Sait Gonen
    Hormones, 2023, 22 : 595 - 602
  • [43] Dosimetric dependencies on target geometry and size in radioiodine therapy for differentiated thyroid cancer
    Nilsson, Joachim N.
    Siikanen, Jonathan
    Lundgren, Catharina Ihre
    Ardenfors, Oscar
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2022, 99 : 68 - 72
  • [44] Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis
    Dicuonzo, Samantha
    Pedretti, Sara
    Mangoni, Monica
    Monari, Fabio
    Fanetti, Giuseppe
    Borsatti, Eugenio
    Lombardi, Davide
    Vianello, Federica
    Iacobone, Maurizio
    Corvo, Renzo
    Magrini, Stefano M.
    Pappagallo, Giovanni
    Arcangeli, Stefano
    D'Angelillo, Rolando M.
    TUMORI JOURNAL, 2021, 107 (06): : 489 - 497
  • [45] Radioiodine Ablation for Differentiated Thyroid Cancer-None, One Dose or Two?
    Rees, G. J. G.
    CLINICAL ONCOLOGY, 2010, 22 (02) : 131 - 135
  • [46] Fractionated dosage of radioiodine for the ablation of low-risk differentiated thyroid cancer has no impact on survival
    Wolinski, Kosma
    Czepczynski, Rafal
    Stangierski, Adam
    Trojanowski, Maciej
    Rewaj-Losyk, Magdalena
    Ziemnicka, Katarzyna
    Baczyk, Maciej
    Dyzmann-Sroka, Agnieszka
    Ruchala, Marek
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (03) : 230 - 234
  • [47] Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications
    Van Nostrand, Douglas
    THYROID, 2018, 28 (09) : 1083 - 1093
  • [48] Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
    Pacilio, Massimiliano
    Conte, Miriam
    Frantellizzi, Viviana
    De Feo, Maria Silvia
    Pisani, Antonio Rosario
    Marongiu, Andrea
    Nuvoli, Susanna
    Rubini, Giuseppe
    Spanu, Angela
    De Vincentis, Giuseppe
    DIAGNOSTICS, 2022, 12 (07)
  • [49] The association between the interval of radioiodine treatment and treatment response, and side effects in patients with lung metastases from differentiated thyroid cancer
    Wang, Hongxi
    Shi, Lei
    Huang, Rui
    Liu, Bin
    Tian, Rong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [50] Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
    Wirth, Lori J.
    Durante, Cosimo
    Topliss, Duncan J.
    Winquist, Eric
    Robenshtok, Eyal
    Iwasaki, Hiroyuki
    Luster, Markus
    Elisei, Rossella
    Leboulleux, Sophie
    Tahara, Makoto
    ONCOLOGIST, 2022, 27 (07) : 565 - 572
12345